Published in Mol Cell Biol on August 01, 1996
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron (2007) 4.47
ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5'UTR. Genes Dev (2002) 3.71
p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell (2007) 3.40
E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1). J Cell Biol (1998) 2.81
p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J (2001) 2.45
A U-rich element in the 5' untranslated region is necessary for the translation of p27 mRNA. Mol Cell Biol (2000) 2.08
Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev (1997) 2.05
A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J (2002) 1.99
Control of cyclin-dependent kinase inhibitor p27 expression by cap-independent translation. Mol Cell Biol (2001) 1.50
p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice. Proc Natl Acad Sci U S A (1999) 1.48
Polypyrimidine tract-binding protein enhances the internal ribosomal entry site-dependent translation of p27Kip1 mRNA and modulates transition from G1 to S phase. Mol Cell Biol (2005) 1.42
Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. J Cell Biol (2000) 1.40
Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle. Mol Cell Biol (2005) 1.37
Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol Cell Biol (1998) 1.36
Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol (2000) 1.35
Staying alive: metabolic adaptations to quiescence. Cell Cycle (2012) 1.28
Regulation of expression by promoters versus internal ribosome entry site in the 5'-untranslated sequence of the human cyclin-dependent kinase inhibitor p27kip1. Nucleic Acids Res (2005) 1.24
EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Mol Biol Cell (2003) 1.21
Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol (1998) 1.15
Noncatalytic requirement for cyclin A-cdk2 in p27 turnover. Mol Cell Biol (2004) 1.06
miR-181a regulates cap-dependent translation of p27(kip1) mRNA in myeloid cells. Mol Cell Biol (2009) 1.04
Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol Cell Biol (2000) 0.98
Embryonic lethal abnormal vision-like HuR-dependent mRNA stability regulates post-transcriptional expression of cyclin-dependent kinase inhibitor p27Kip1. J Biol Chem (2010) 0.96
Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition. Mol Cell Biol (2007) 0.95
Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells. Am J Physiol Gastrointest Liver Physiol (2010) 0.94
Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line. World J Gastroenterol (2000) 0.92
Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells. Mol Biol Cell (1998) 0.91
The major transcription initiation site of the p27Kip1 gene is conserved in human and mouse and produces a long 5'-UTR. BMC Mol Biol (2001) 0.91
Cap-independent translation through the p27 5'-UTR. Nucleic Acids Res (2007) 0.91
Towards a systems biology approach to mammalian cell cycle: modeling the entrance into S phase of quiescent fibroblasts after serum stimulation. BMC Bioinformatics (2009) 0.91
"Nutritional and chemopreventive anti-cancer agents up-regulate expression of p27Kip1, a cyclin-dependent kinase inhibitor, in mouse JB6 epidermal and human MCF7, MDA-MB-321 and AU565 breast cancer cells". Cancer Cell Int (2006) 0.90
Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1). Mol Biol Cell (2000) 0.87
A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation. Oncogene (2011) 0.83
P27kip1 regulates the cell cycle arrest and survival of activated T lymphocytes in response to interleukin-2 withdrawal. Immunology (2003) 0.82
S10 phosphorylation of p27 mediates atRA induced growth arrest in ovarian carcinoma cell lines. J Cell Physiol (2008) 0.82
Upstream molecular signaling pathways of p27(Kip1) expression: effects of 4-hydroxytamoxifen, dexamethasone, and retinoic acids. Cancer Cell Int (2010) 0.81
Upstream molecular signaling pathways of p27(Kip1) expression in human breast cancer cells in vitro: differential effects of 4-hydroxytamoxifen and deficiency of either D-(+)-glucose or L-leucine. Cancer Cell Int (2011) 0.79
Estrogen-induced proliferation in cultured hepatocytes involves cyclin D1, p21(Cip1) and p27(Kip1). Dig Dis Sci (2006) 0.78
The non-canonical functions of p27(Kip1) in normal and tumor biology. Cell Cycle (2016) 0.78
Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1. BMC Cancer (2011) 0.78
p27Kip1 inhibits the cell cycle through non-canonical G1/S phase-specific gatekeeper mechanism. Cell Cycle (2015) 0.77
Expression of p27Kip1, a cell cycle repressor protein, is inversely associated with potential carcinogenic risk in the genetic rodent models of obesity and long-lived Ames dwarf mice. Metabolism (2013) 0.76
Mechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in glioma. Mol Oncol (2011) 0.75
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell (1993) 33.20
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (1993) 13.68
Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev (1995) 13.66
Principles of CDK regulation. Nature (1995) 13.09
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (1995) 9.79
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell (1994) 9.48
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell (1994) 8.90
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev (1994) 8.52
Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell (1991) 8.00
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev (1993) 7.41
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev (1993) 7.40
D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol (1994) 7.35
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell (1993) 7.19
Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol (1995) 6.41
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science (1992) 6.40
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem (1995) 6.25
Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell (1992) 6.08
Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell (1991) 5.98
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev (1995) 5.63
Crystal structure of cyclin-dependent kinase 2. Nature (1993) 5.21
Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci U S A (1977) 5.20
Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol (1994) 5.18
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (1994) 5.12
Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev (1995) 4.94
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell (1991) 4.88
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev (1995) 4.87
Growth factors and cancer. Science (1991) 4.54
Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A (1995) 4.54
Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J (1992) 4.21
Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev (1995) 4.19
p21-containing cyclin kinases exist in both active and inactive states. Genes Dev (1994) 4.08
Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev (1992) 3.96
Regulation of the cyclin E gene by transcription factor E2F1. Proc Natl Acad Sci U S A (1995) 3.95
Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell (1994) 3.74
Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev (1993) 3.70
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA. Nature (1995) 3.56
Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc Natl Acad Sci U S A (1992) 3.38
Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science (1993) 3.28
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol (1995) 3.19
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature (1995) 3.11
Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci U S A (1994) 3.03
An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci U S A (1978) 2.71
Activation of human cyclin-dependent kinases in vitro. Mol Biol Cell (1992) 2.68
A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr Biol (1995) 2.57
Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol (1995) 2.47
Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts. Proc Natl Acad Sci U S A (1992) 2.43
Early events in DNA replication require cyclin E and are blocked by p21CIP1. J Cell Biol (1995) 2.34
Formation of p27-CDK complexes during the human mitotic cell cycle. Cell Growth Differ (1996) 2.18
Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol Biol Cell (1995) 2.18
Cdk inhibitors: on the threshold of checkpoints and development. Curr Opin Cell Biol (1994) 2.12
CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proc Natl Acad Sci U S A (1992) 2.05
E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity. Genes Dev (1995) 1.95
Regulation of the cell cycle machinery by oncogenic ras. Oncogene (1996) 1.92
Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol (1994) 1.85
The pRB-related protein p107 contains two growth suppression domains: independent interactions with E2F and cyclin/cdk complexes. EMBO J (1995) 1.67
Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. EMBO J (1995) 1.59
Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. Oncogene (1995) 1.59
Cyclin E and cyclin A as candidates for the restriction point protein. Cancer Res (1993) 1.57
Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene (1995) 1.53
Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol (1995) 1.52
p53-dependent repression of CDK4 translation in TGF-beta-induced G1 cell-cycle arrest. Genes Dev (1995) 1.50
The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J Biol Chem (1995) 1.37
Novel mammalian cyclins (CYL genes) expressed during G1. Cold Spring Harb Symp Quant Biol (1991) 1.29
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells. Mol Cell Biol (1994) 1.29
Cyclins and their partners during Xenopus oocyte maturation. Cold Spring Harb Symp Quant Biol (1991) 1.20
The cell cycle kinases. Semin Cancer Biol (1994) 1.09
Activation of the p34 CDC2 protein kinase at the start of S phase in the human cell cycle. Mol Biol Cell (1992) 1.08
Chromosomal mapping of members of the cdc2 family of protein kinases, cdk3, cdk6, PISSLRE, and PITALRE, and a cdk inhibitor, p27Kip1, to regions involved in human cancer. Cancer Res (1995) 1.06
Exploring the role of Drosophila cyclin A in the regulation of S phase. Cold Spring Harb Symp Quant Biol (1991) 1.05
Mammalian antiproliferative signals and their targets. Curr Opin Genet Dev (1995) 1.03
Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210. J Cell Biol (1992) 1.01
Cyclins and their associated cyclin-dependent kinases in the human cell cycle. Biochem Soc Trans (1993) 1.00
Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J Biol Chem (1996) 0.96
Regulation of CYL/cyclin D genes by colony-stimulating factor 1. Ciba Found Symp (1992) 0.90
Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells. Cell Growth Differ (1995) 0.85
Inhibition of G1 phase cyclin dependent kinases by transforming growth factor beta 1. J Cell Biochem (1994) 0.80
Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci U S A (1977) 5.20
Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci U S A (1979) 4.32
Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med (2001) 4.27
Molecular pathology of endometrial hyperplasia and carcinoma. Hum Pathol (2001) 3.80
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci U S A (2001) 3.29
Use of selectively trypsinized nucleosome core particles to analyze the role of the histone "tails" in the stabilization of the nucleosome. J Mol Biol (1989) 2.95
Hydrogen peroxide is involved in abscisic acid-induced stomatal closure in Vicia faba. Plant Physiol (2001) 2.91
Synthesis of nitric oxide in CNS glial cells. Trends Neurosci (1993) 2.81
Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells. Mol Cell Biol (1989) 2.78
Genetic and clinical features of 42 kindreds with resistance to thyroid hormone. The National Institutes of Health Prospective Study. Ann Intern Med (1995) 2.74
An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci U S A (1978) 2.71
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemia. Diabetes Care (1997) 2.63
Interlaboratory comparison of ultrasonic backscatter, attenuation, and speed measurements. J Ultrasound Med (1999) 2.47
Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature (1995) 2.45
Inguinal hernia: a common problem of premature infants weighing 1,000 grams or less at birth. Pediatrics (1975) 2.34
Model of complications of NIDDM. I. Model construction and assumptions. Diabetes Care (1997) 2.32
A conserved repetitive DNA element located in the centromeres of cereal chromosomes. Proc Natl Acad Sci U S A (1996) 2.32
Isoleucine and valine metabolism in Escherichia coli. XXII. A pleiotropic mutation affecting induction of isomeroreductase activity. J Bacteriol (1973) 2.31
Overt and subclinical hypothyroidism complicating pregnancy. Thyroid (2002) 2.30
Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells. J Cell Biol (1985) 2.26
Relaxation of a transfer RNA specificity by removal of modified nucleotides. Nature (1990) 2.20
Role of the histone "tails" in the folding of oligonucleosomes depleted of histone H1. J Biol Chem (1992) 2.17
Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells. Exp Cell Res (1982) 2.13
Isoleucine and valine metabolism in Escherichia coli. XX. Multiple forms of acetohydroxy acid synthetase. Biochem Biophys Res Commun (1972) 2.07
Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene (2000) 2.06
Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology (2000) 2.03
Sleeping sickness in West Africa (1906-2006): changes in spatial repartition and lessons from the past. Trop Med Int Health (2008) 2.00
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol (1997) 1.97
Conformation in solution of yeast tRNA(Asp) transcripts deprived of modified nucleotides. Biochimie (1990) 1.97
A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol (2001) 1.93
Regulation of the cell cycle machinery by oncogenic ras. Oncogene (1996) 1.92
Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc Natl Acad Sci U S A (1981) 1.90
Liquid or solid ultrasonically tissue-mimicking materials with very low scatter. Ultrasound Med Biol (1998) 1.84
Retrotransposon-related DNA sequences in the centromeres of grass chromosomes. Genetics (1998) 1.80
Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor. J Cell Physiol (1978) 1.79
Isoleucine and valine metabolism in Escherichia coli. XXI. Mutations affecting derepression and valine resistance. J Bacteriol (1973) 1.75
Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene (2000) 1.75
Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report. Acta Paediatr Suppl (2002) 1.63
Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med (2001) 1.63
Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation. EMBO J (1997) 1.57
Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev (1999) 1.54
Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancet (1995) 1.53
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J (2001) 1.50
Sequence of human villin: a large duplicated domain homologous with other actin-severing proteins and a unique small carboxy-terminal domain related to villin specificity. J Cell Biol (1988) 1.49
Overlapping roles of pocket proteins in the myocardium are unmasked by germ line deletion of p130 plus heart-specific deletion of Rb. Mol Cell Biol (2005) 1.48
Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer (2009) 1.48
Isolation and characterization of SYN1, a RAD21-like gene essential for meiosis in Arabidopsis. Plant Cell (1999) 1.48
Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest (1992) 1.48
Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study. Dermatol Surg (1996) 1.47
A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest (1990) 1.42
Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase. RNA (2001) 1.42
Behavior of resting Aedes aegypti (Culicidae: Diptera) and its relation to ultra-low volume adulticide efficacy in Panama City, Panama. J Med Entomol (2000) 1.41
Kidney graft survival in patients with hepatitis C: a single center experience. Clin Transplant (2008) 1.41
Complications of foreign bodies in the esophagus. Otolaryngol Head Neck Surg (2000) 1.41
Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc Natl Acad Sci U S A (1991) 1.40
Radiotracer synthesis from [(11)C]-iodomethane: a remarkably simple captive solvent method. Nucl Med Biol (2000) 1.39
Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (1999) 1.37
Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. Exp Cell Res (1983) 1.36
An admonition when measuring the lipophilicity of radiotracers using counting techniques. Appl Radiat Isot (2001) 1.36
A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. J Card Fail (2001) 1.35
A human villin cDNA clone to investigate the differentiation of intestinal and kidney cells in vivo and in culture. EMBO J (1986) 1.35
Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc Natl Acad Sci U S A (1984) 1.30
The A-kinase anchor protein MAP2B and cAMP-dependent protein kinase are associated with class C L-type calcium channels in neurons. J Biol Chem (1999) 1.29
Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes. Mol Pharmacol (2009) 1.29
Reliability and acceptability of psychiatric diagnosis via telecommunication and audiovisual technology. Psychiatr Serv (1998) 1.27
Interferon inhibits the establishment of competence in Go/S-phase transition. Science (1986) 1.26
Control of the Balb/c-3T3 cell cycle by nutrients and serum factors: analysis using platelet-derived growth factor and platelet-poor plasma. J Cell Physiol (1979) 1.24
Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. Vaccine (1999) 1.24
The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg (1996) 1.23
A model of cell cycle control: sequential events regulated by growth factors. Mol Cell Endocrinol (1983) 1.23
Rapidly destructive hip disease: clinical and imaging abnormalities. Radiology (1993) 1.23
Transformation by v-myb correlates with trans-activation of gene expression. Mol Cell Biol (1990) 1.23
Biofilm formation by Acinetobacter baumannii. Microbios (1996) 1.23
Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance: role of Akt phosphorylation, PTB1B, PPARgamma and c-Jun. Diabetologia (2005) 1.23
Reported social alcohol consumption during pregnancy and infants' development at 18 months. BMJ (1991) 1.22
Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J Virol (1996) 1.22
Stress reactivity of the brain noradrenergic system in three rat strains differing in their neuroendocrine and behavioral responses to stress: implications for susceptibility to stress-related neuropsychiatric disorders. Neuroscience (2002) 1.21
Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites? Acta Trop (2006) 1.21
Comparison of different DNA preparation protocols for PCR diagnosis of Human African Trypanosomosis in Côte d'Ivoire. Acta Trop (2002) 1.21
The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine (1997) 1.21
Requirements for nuclear localization and supramolecular assembly of a baculovirus polyhedrin protein. Virology (1991) 1.20
Biosynthesis and processing of the Autographa californica nuclear polyhedrosis virus gp64 protein. Virology (1994) 1.20
Macrophage-fibroblast interactions in collagenase production and cartilage degradation. Biochem J (1979) 1.20
Workplace bullying and sleep disturbances: findings from a large scale cross-sectional survey in the French working population. Sleep (2009) 1.19
P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation. J Thromb Haemost (2006) 1.19
Construction of a bacterial artificial chromosome (BAC) library for potato molecular cytogenetics research. Genome (2000) 1.18
Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer. Ann Oncol (2007) 1.18
Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity. Oncogene (2000) 1.16
Mood and cognitive side effects of interferon-alpha therapy. Semin Oncol (1998) 1.16
The relationship between parental genetic or phenotypic divergence and progeny variation in the maize nested association mapping population. Heredity (Edinb) (2011) 1.16
Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis. Proc Natl Acad Sci U S A (1982) 1.16
HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Virology (1991) 1.15
Mitogenic activity elaborated by macrophage-like cell lines acts as competence factor(s) for BALB/c 3T3 cells. J Cell Physiol (1982) 1.15
P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol Cell Biol (2003) 1.14
Degradation of cartilage proteoglycans by a neutral proteinase secreted by rabbit bone-marrow macrophages in culture. Biochem J (1978) 1.14
[The impact of war on the evolution of sleeping sickness in west-central Côte d'Ivoire]. Trop Med Int Health (2006) 1.14
Myositis ossificans: aftermath of elbow injuries. Clin Orthop Relat Res (1967) 1.13
Digital mapping of bacterial artificial chromosomes by fluorescence in situ hybridization. Plant J (1999) 1.13
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2006) 1.13